Nothing Special   »   [go: up one dir, main page]

Favero et al., 2019 - Google Patents

Inflammatory molecules produced by meniscus and synovium in early and end‐stage osteoarthritis: a coculture study

Favero et al., 2019

View PDF
Document ID
8010033473637496256
Author
Favero M
Belluzzi E
Trisolino G
Goldring M
Goldring S
Cigolotti A
Pozzuoli A
Ruggieri P
Ramonda R
Grigolo B
Punzi L
Olivotto E
Publication year
Publication venue
Journal of cellular physiology

External Links

Snippet

The aim of this study was to identify the molecules and pathways involved in the cross‐talk between meniscus and synovium that may play a critical role in osteoarthritis (OA) pathophysiology. Samples of synovium and meniscus were collected from patients with …
Continue reading at www.research.unipd.it (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis

Similar Documents

Publication Publication Date Title
Favero et al. Inflammatory molecules produced by meniscus and synovium in early and end‐stage osteoarthritis: a coculture study
Chou et al. Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis
Diekman et al. Expression of p16 INK 4a is a biomarker of chondrocyte aging but does not cause osteoarthritis
Hsueh et al. Synergistic roles of macrophages and neutrophils in osteoarthritis progression
Li et al. XIST/miR‐376c‐5p/OPN axis modulates the influence of proinflammatory M1 macrophages on osteoarthritis chondrocyte apoptosis
Eymard et al. Induction of an inflammatory and prodegradative phenotype in autologous fibroblast‐like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis
Liang et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells
Platas et al. Conditioned media from adipose‐tissue‐derived mesenchymal stem cells downregulate degradative mediators induced by interleukin‐1β in osteoarthritic chondrocytes
Assirelli et al. Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro
Nakamura et al. Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration
Wang et al. LncRNA H19 targets miR‐22 to modulate H2O2‐induced deregulation in nucleus pulposus cell senescence, proliferation, and ECM synthesis through Wnt signaling
Xu et al. The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis
Liu The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis
Tchetina et al. Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity
McCarthy et al. Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes
Bougault et al. Stress‐induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models
Johnson et al. TNF-α promotes nuclear enrichment of the transcription factor TonEBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells
Long et al. Rac1 is required for matrix metalloproteinase 13 production by chondrocytes in response to fibronectin fragments
Zhou et al. Influence of osteoarthritis grade on molecular signature of human cartilage
Li et al. The protective effect of sinapic acid in osteoarthritis: In vitro and in vivo studies
Wang et al. Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival
Wilson et al. Novel elements of the chondrocyte stress response identified using an in vitro model of mouse cartilage degradation
Fioravanti et al. Exploring the Involvement of NLRP3 and IL‐1β in Osteoarthritis of the Hand: Results from a Pilot Study
Han et al. Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration
Bao et al. circFAM160A2 promotes mitochondrial stabilization and apoptosis reduction in osteoarthritis chondrocytes by targeting miR‐505‐3p and SIRT3